07/10/15 10:18 AM H.R. 6
DEBATE - Pursuant to the provisions of H. Res. 350, the Committee of the Whole proceeded with 10 minutes of debate on the Polis amendment No. 7.
07/10/15 10:18 AM H.R. 6
An amendment, offered by Mr. Polis, numbered 7 printed in House Report 114-193 to direct the Food and Drug Administration to issue a report on the risks and benefits associated with a two-tiered approval process that would permit certain medical devices to provisionally come to market if they have demonstrated safety but not efficacy.
07/10/15 10:18 AM H.R. 6
On agreeing to the Fitzpatrick amendment; Agreed to by voice vote.
07/10/15 10:11 AM H.R. 6
DEBATE - Pursuant to the provisions of H. Res. 350, the Committee of the Whole proceeded with 10 minutes of debate on the Fitzpatrick amendment No. 6.
07/10/15 10:11 AM H.R. 6
An amendment, offered by Mr. Fitzpatrick, numbered 6 printed in House Report 114-193 to express a sense of Congress that recording Unique Device Identifiers at the point-of-care in electronic health record systems could significantly enhance the availability of medical device data for post-market surveillance purposes.
07/10/15 10:10 AM H.R. 6
On agreeing to the Slaughter amendment; Agreed to by voice vote.
07/10/15 9:58 AM H.R. 6
DEBATE.
07/10/15 9:58 AM H.R. 6
DEBATE - Pursuant to the provisions of H. Res. 350, the Committee of the Whole proceeded with 10 minutes of debate on the Slaughter amendment No. 5.
07/10/15 9:58 AM H.R. 6
An amendment, offered by Ms. Slaughter, numbered 5 printed in House Report 114-193 to direct the CDC to conduct a study to determine how the additional payments are affecting the development of drug resistance.
07/10/15 9:57 AM H.R. 6
On agreeing to the Castro (TX) amendment; Agreed to by voice vote.
